Management of Symptomatic Vascularized Retained Products of Conception by Proximal Uterine Artery Embolization with Gelatin Sponge Torpedoes.


Journal

Journal of vascular and interventional radiology : JVIR
ISSN: 1535-7732
Titre abrégé: J Vasc Interv Radiol
Pays: United States
ID NLM: 9203369

Informations de publication

Date de publication:
11 2022
Historique:
received: 20 01 2022
revised: 02 06 2022
accepted: 12 07 2022
pubmed: 23 7 2022
medline: 15 12 2022
entrez: 22 7 2022
Statut: ppublish

Résumé

To evaluate the effectiveness and safety of temporary proximal uterine artery embolization (UAE) for the treatment of highly vascularized retained products of conception (RPOCs). This retrospective analysis included women who underwent treatment for vaginal bleeding after abortion, miscarriage, or delivery, with highly vascularized RPOCs detected by Doppler ultrasound (US) (ie, presence of an enhanced myometrial vascularity, a low resistance index of <0.5, and a peak systolic velocity of ≥0.7 m/s). A unilateral or bilateral embolization with torpedoes of gelatin foam was performed. From November 2017 to January 2021, 24 women with a median age of 30 years (interquartile range, 26.0-34.5 years) with symptomatic highly vascularized RPOCs were included. Clinical success was defined as bleeding arrest between the UAE and 1-month follow-up. Technical success was defined as the complete obstruction of at least 1 uterine artery supplying vascular abnormalities. The safety of the procedure according to the classification of the Society of Interventional Radiology and evolution of lesions on US were also reported. Technical success was achieved in all 24 (100%) patients, with bilateral arterial embolization in 19 (79%) patients and unilateral embolization in 5 (21%) patients. Clinical success was achieved in all 24 (100%) patients. Five patients still had uterine retention at the 1-month follow-up, including 2 patients with highly vascularized RPOCs. Two patients benefited from hysteroscopy, and 3 had noninvasive management. Four minor adverse events were reported (1 patient had infectious endometritis and 3 patients had a postembolization syndrome). Proximal UAE with torpedoes of gelatin foam is safe and effective for the management of symptomatic highly vascularized RPOCs.

Identifiants

pubmed: 35868595
pii: S1051-0443(22)01074-0
doi: 10.1016/j.jvir.2022.07.018
pii:
doi:

Substances chimiques

Gelatin 9000-70-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1313-1320

Informations de copyright

Copyright © 2022 SIR. Published by Elsevier Inc. All rights reserved.

Auteurs

Eliott Mathieu (E)

University of Grenoble Alpes, Grenoble, France; Department of Radiology, Grenoble Alpes University Hospital, Grenoble, France.

Didier Riethmuller (D)

University of Grenoble Alpes, Grenoble, France; Department of Obstetrics and Gynecology, Grenoble Alpes University Hospital, Grenoble, France.

Aurélie Delouche (A)

Department of Radiology, Grenoble Alpes University Hospital, Grenoble, France.

Marie Sicot (M)

Department of Obstetrics and Gynecology, Grenoble Alpes University Hospital, Grenoble, France.

Yann Teyssier (Y)

Department of Radiology, Grenoble Alpes University Hospital, Grenoble, France.

Mathieu Finas (M)

Department of Radiology, Grenoble Alpes University Hospital, Grenoble, France.

Bénédicte Guillaume (B)

Department of Radiology, Grenoble Alpes University Hospital, Grenoble, France.

Frederic Thony (F)

Department of Radiology, Grenoble Alpes University Hospital, Grenoble, France.

Gilbert Ferretti (G)

University of Grenoble Alpes, Grenoble, France; Department of Radiology, Grenoble Alpes University Hospital, Grenoble, France.

Julien Ghelfi (J)

University of Grenoble Alpes, Grenoble, France; Department of Radiology, Grenoble Alpes University Hospital, Grenoble, France; INSERM U1209/CNRS UMR 5309, Institute for Advanced Biosciences, University of Grenoble Alpes, Grenoble, France. Electronic address: jghelfi@chu-grenoble.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH